ABC | Volume 111, Nº5, November 2018

Original Article Albertini et al The role of preoperative venography in reoperations Arq Bras Cardiol. 2018; 111(5):686-696 7. Korkeila P, Nyman K, Ylitalo A, Koistinen J, Karjalainen P, Lund J, et al. Venous obstruction after pacemaker implantation. Pacing Clin Electrophysiol. 2007;30(2):199-206. 8. Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace. 2007;9(5):328-32. 9. Costa R, Silva KR, Rached RA, Martinelli Filho M, Carnevale FC, Moreira LFP, Stolf NAG. Prevention of 
venous thrombosis by warfarin after permanent transvenous leads implantation in high-risk patients. 
 Pacing Clin Electrophysiol. 2009;32(Suppl 1):S247-51. 10. Pieper CC, Weis V, Fimmers R, Rajab I, Linhart M, Schild HH, et al. Venous obstruction in asymptomatic patients undergoing first implantation or revision of a cardiac pacemaker or implantable cardioverter-defibrillator: A Retrospective Single Center Analysis. RoFo. 2015;187(11):1029-35. 11. Boczar K, Zabek A, Haberka K, Hardzina M, Debski M, Rydlewska A, et al. Venous stenosis and occlusion in the presence of endocardial leads . Adv Clin Exp Med. 2016;25(1):83-91. 12. Lin CT, Kuo CT, Lin KH, Hsu TS. Superior vena cava syndrome as a complication of transvenous permanent pacemaker implantation. JpnHeart J. 1999;40(4):477-80. 13. Sbragia P, Nait-Saïdi L, Trigano JA, Saadjian A, Barnay P, Lévy S. Intra- atrial thrombosis and pulmonary embolism complicating pacemaker leads for cardiac resynchronization therapy. J Interv Card Electrophysiol .2003;9(1):25-7. 14. Aryana A, Sobota KD, Esterbrooks DJ, Gelbman AI. Superior vena cava syndrome induced by endocardial defibrillator and pacemaker leads. Am J Cardiol .2007;99(12):1765-7. 15. Noheria A, Ponamgi SP, Desimone C V, Vaidya VR, Aakre CA, Ebrille E, et al. Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads. Europace . 2015;18(2):246-52. 16. Korkeila P, Mustonen P, Koistinen J, Nyman K, Ylitalo A, Karjalainen P, et al. Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study. Europace . 2010;12(6):817-24. 17. Brasil. Ministério da Saúde. DATASUS - Secretaria Executiva. [Citado em 2017 dez 12]. Disponível em: http://w3.datasus.gov.br/datasus/datasus.php 18. Li X, Ze F, Wang L, Li D, Duan J, Guo F, et al. Prevalence of venous occlusion in patients referred for lead extraction: implications for tool selection. Europace . 2014;16(12):1795-9. 19. Harrison JL, Prendergast BD, Sandoe JA. Guidelines for the diagnosis, management and prevention of implantable cardiac electronic device infection. Heart. 2015;101(4):250-2. 20. UslanDZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM,et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669-75. 21. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation .2007;116(12):1349-55. 22. deOliveira JC, Martinelli M, Nishioka SA, Varejão T, Uipe D, Pedrosa AA, et al. Efi cacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;(1):29-34. 23. GreensponAJ,PatelJD,LauE,OchoaJA,FrischDR,HoRT,etal.16-yeartrendsin theinfectionburdenforpacemakersandimplantablecardioverter-defibrillators in theUnited States 1993 to 2008. J AmColl Cardiol. 2011;58(10):1001-6. 24. Martinelli M, Lorga A, Fagundes AA, Barros ARC, De Paola AAV, Pedrosa A, et al; Sociedade Brasileira de Cardiologia. Diretrizes Brasileiras de Dispositivos Cardíacos Eletrônicos Implantáveis (DCEI). Arq Bras Cardiol. 2007;89(6):e210-37. 25. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart RhythmSociety. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ AmericanHeart Association Task Force on PracticeGuidelines and theHeart RhythmSociety. Circulation. 2013;127(3):e283-352. 26. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070-118. 27. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, et al.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240-327. 28. Marx E, Schulte HD, Balau J, Buyusch KH. Phlebographic and clinical early and late findings in transvenously implanted pacemaker electrodes. Z Kreislaufforsch .1972;61(2):115-23. 29. StoneyWS, Addlestone RB, AlfordWC Jr, Burrus GR, Frist RA, Thomas CS Jr. The incidence of venous thrombosis following long term transvenous pacing. Ann Thorac Surg. 1976;22(2):166-70. 30. Fritz T, Richeson JF, Fitzpatrick P, Wilson G. Venous obstruction: a potential complicationoftransvenouspacemakerelectrodes. Chest. 1983;83(3):534-9. 31. Mustafa BO, Rathbun SW,Whitsett TL, RaskobGE. Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review. Arch Intern Med. 2002; 25:162(4):401-4. 32. Baarslag HJ, van Beek EJ, Koopman MM, Reekers JA. Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med .2002;136(12):865-72. 33. Bettmann MA. Noninvasive and venographic diagnosis of deep vein thrombosis. Cardiovasc Intervent Radiol. 1988;11(Suppl)S15-20. 34. Baldt MM, Zontsich T, Kainberger F, Fleischmann G, Mostbeck G. Spiral CT evaluation of deep venous thrombosis. 35. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCAP) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377-81. 36. Hosoda J, Toshiyuki I, Matsumoto K, Sugano T, Ishigami T, Kimura K , et al. Clinicalsignificanceofcollateralsuperficialveinacrossclavicle inpatientswith cardiovascular implantable electronic device. Circ J. 2014;78(8) : 1846-50. 37. Abu-El-Haija B, Bhave P, Campbell D, Mazur A, Hodgson-Zingman D, Cotarlan V, et al. Venous stenosis after transvenous lead placement: A Study of Outcomes and Risk Factors in 212Consecutive Patients. J AmHeart Assoc . 2015;4(8):e001878 695